Aurora cannabis announces fiscal 2024 second quarter results and delivers record positive adjusted ebitda

Nasdaq | tsx: acb delivers record positive adjusted ebitda 1 of $ 3.4 million quarterly net revenue 1 rose 30% yoy to $63.4 million; strong growth of 42 % in global medical cannabis net cash position of over $200 million , expects to repay the remaining us$5.3 million balance of convertible senior notes in february 2024 re-affirms target of achieving positive free cash flow 1 in calendar year 2024 edmonton, ab , nov. 9, 2023 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: acb) (tsx: acb), the canadian company opening the world to cannabis, today announced its financial and operational results for the second quarter of fiscal year 2024. as the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for q2 2024 ending september 30, 2023, is q1 2023 ending september 30, 2022.
ACB Ratings Summary
ACB Quant Ranking